Abstract
The phenomenon of tolerance was described for the first time by Stewart in 1888 (32, 33). He wrote about a patient, in whom it took 20 grains of nitroglycerin to produce the same hypotensive effect as was initially achieved with 1/100 grain. Subsequently, a number of reports were published concerning the diminishing effects of nitrates during chronic treatment in respect to heart rate, blood pressure, and headache (5, 11, 12, 30, 35). On the other hand, withdrawal symptoms after chronic use of nitrates were seen (15, 27). The experiences with workers in dynamite factories are well known (9, 17, 20, 34). Definitions of tolerance, tachyphylaxis, and so on are given in Table 1. The main problem in chronic treatment with nitrates is whether tolerance occurs or not. We have carried out three studies and started a fourth with a view to providing an answer to this question.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrams J: Nitrate tolerance and dependence. Amer Heart J Vol 99, 1 S. 113–122 (1980).
Abrams J: Nitrate tolerance and dependence. La Nouvelle Presse Medicale 9, No. 34 S. 2499–2504 (1980).
Aronow WS, Chesluk HM: Evaluation of nitroglycerin in angina in patients on isosorbide dinitrate. Circulation 42: 61–63 (1970).
Becker HJ, Waiden G, Kaltenbach M: Gibt es eine „Tachyphylaxie“ bzw. Gewöhnung bei der Behandlung der Angina pectoris mit Nitrokörpern? Verh Dtsch Ges Inn Med 82. Bd. 1208–1210, J. F. Bergmann München 1976.
Bernstein LM, Ivy AC: Inositol and mannitol hexanitrates in hypertensive management. Circulation 12: 353 (1955).
Blasini R, Brügmann U, Mannes A, Froer KL, Hall D, Rudolph W: Wirksamkeit von ISDN in retardierter Form bei Langzeitbehandlung. Herz 5: 298–305 (1980).
Blasini R, Brügmann U, Froer KL, Fleck E, Rudoph W: Gibt es eine Toleranzentwicklung bei oraler Langzeitbehandlung mit Nitraten? Verh Dtsch Ges Inn Med Bd. 88, J. F. Bergmann München 1982, im Druck.
Brunner D, Weisbord J, Meshulam N, Margulis S: Langzeitwirkung und Dauertherapie mit kutan appliziertem ISDN bei Patienten mit koronarer Herzkrankheit. Münch Med Wschr 122: 21, 801–806(1980).
Carmichel P, Lieben J: Sudden death in explosives workers. Arch Environ Health 7: 50–54 (1963).
Chandraratna PAN, Langevin E, O’Dell R, Rubinstein C, San Pedro S: Use of nitroglycerin ointment in congestive heart failure. Cardiology 63: 337–339 (1978).
Crandall LA, Leake CD, Loevenheart AS, Mühlberger CW: Acquired tolerance to and cross tolerance between the nitrous and nitric acid esters and sodium nitrite in man. 3. Pharmacol Exp Ther 41: 103–120 (1931).
Danahy DT, Aronow WS: Hemodynamics and antianginal effects of high dose oral ISDN after chronic use. Circulation 56: 205–212 (1977).
Franciosa JA, Miculic E, Cohn JN, Jose E, Fabie A: Hemodynamic effects of orally administered ISDN in patients with congestive heart failure. Circulation 50: 1020–1024 (1974).
Franciosa JA, Cohn JN: Sustained hemodynamic effects of nitrates without tolerance in heart failure. Circulation 57/58: S. 11–28 (1978).
Franciosa JA, Nordstrom LA, Cohn JN: Nitrate therapy for congestive heart failure. D Amer Med Ass 240: 443 (1978).
Goldstein RE, Rosing DR, Redwood DR, Beisef GD, Epstein SE: Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation 43: 629–640 (1971).
Klock JC: Nonocclusive coronary disease after chronic exposure to nitrates: evidence for physiologic nitrate dependence. Amer Heart J 89: 510 (1975).
Kovick RB, Tillisch JH, Berens SC, Bramowitz AD, Shine KI: Vasodilator therapy of chronic left ventricular failure. Circulation 53: 322 (1976).
Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Collidge G: Non-atheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 46: 666 (1972).
Laws GC: The effects of nitroglycerin upon those who manufacture it. Am Med Ass 21: 793 (1898).
Lee G, Mason DT, DeMaria AN: Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Amer J Cardiol 41: 82–87 (1978).
Lichtlen PR: Langzeitnitrate bei Angina pectoris. Münch Med Wschr 122: 49, 1753–1754 (1980).
Lund RP, Haggendahl J, Johnsson G: Withdrawal symptoms in workers exposed to nitroglycerine. Br J Inn Med 25: 136 (1968).
Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW: Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Amer J Cardiol 40: 794–801 (1977).
Morikawa Y, Muraki K, Ikoma Y, Honda T, Takamatsu H: Organic nitrate poisoning at an explosives factory. Arch Environ Health 7: 50 (1963).
Morton WE: Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension. J Occup Med 19: 197 (1977).
Muller J, Gunther SJ: Nifedipine therapy for Prinzmetal’s angina. Circulation 57: 737 (1978).
Needleman P, Hunter FE: The transformation of glyceryl trinitrate and other nitrates by glutathione organic nitrate reductase. Molec Pharmacol 1: 77–86 (1965).
Needleman P, Johnson EM: Mechanism of tolerance development organic nitrates. J Pharm Exp Ther 184: 709–715 (1973).
Schelling JL, Lasagna L: A study of cross tolerance to circulatory effects of organic nitrates. Clin pharm Ther 8: 256–260 (1967).
Shane SJ, Iazetta JJ, Chisholm AW, Berka JF, Leung D: Plasma concentrations of isosorbide dinitrate and its metabolites after chronic oral dosage in man. Brit J clin Pharmacol 6: 37–41 (1978).
Stewart DD: Remarkable tolerance to nitroglycerine. Philadelphia Polyclinic, 1888, 172.
Stewart DD: Tolerance to nitroglycerine. J amer med ass 44: 1678–1679 (1905).
Symanski H: Schwere Gesundheitsschädigungen durch berufliche Nitroglykoleinwirkung. Arch Hyg Bakt 136: 139 (1952).
Thadani V, Manyari D, Parker JD, Fung H: Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross tolerance to glyceryl trinitrate. Circulation 61: 526–535 (1980).
Winsor W, Berger HJ: Oral nitroglycerin as a prophylactic antianginal drug: Clinical, physiologic and statistical evidence of efficacy based on a threephase experimental design. Amer Heart J 90:611–626 (1975).
Zelis R, Mason DT: ISDN, effect on the vasodilator response to nitroglycerin. JAMA, 234: 166–170 (1975).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Becker, HJ., Meudt, R., Kretschmer, S., Hüwer, H.D. (1983). Tolerance in Patients with Coronary Heart Disease Under Chronic Treatment with Isosorbide Dinitrate?. In: Kaltenbach, M., Kober, G. (eds) Nitrates and Nitrate Tolerance in Angina Pectoris. Steinkopff. https://doi.org/10.1007/978-3-642-85323-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-85323-4_12
Publisher Name: Steinkopff
Print ISBN: 978-3-642-85325-8
Online ISBN: 978-3-642-85323-4
eBook Packages: Springer Book Archive